310 related articles for article (PubMed ID: 12821359)
1. Low-grade endometrial stromal sarcoma: hormonal aspects.
Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
[TBL] [Abstract][Full Text] [Related]
2. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
Reich O; Regauer S; Urdl W; Lahousen M; Winter R
Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
[TBL] [Abstract][Full Text] [Related]
3. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
[TBL] [Abstract][Full Text] [Related]
4. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.
Balleine RL; Earls PJ; Webster LR; Mote PA; deFazio A; Harnett PR; Clarke CL
Int J Gynecol Pathol; 2004 Apr; 23(2):138-44. PubMed ID: 15084842
[TBL] [Abstract][Full Text] [Related]
5. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
[TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.
Moinfar F; Regitnig P; Tabrizi AD; Denk H; Tavassoli FA
Virchows Arch; 2004 May; 444(5):410-4. PubMed ID: 15007645
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
8. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
[TBL] [Abstract][Full Text] [Related]
9. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
Cade TJ; Quinn MA; Rome RM; Polyakov A
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
[TBL] [Abstract][Full Text] [Related]
11. Low-grade endometrial stromal sarcoma developing in a postmenopausal woman under toremifene treatment for breast cancer.
Kashiyama T; Oda K; Kawana K; Arimoto T; Kanetaka Y; Takazawa Y; Maeda D; Nakagawa S; Yano T; Kozuma S
J Obstet Gynaecol Res; 2013 Jan; 39(1):424-9. PubMed ID: 22690656
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
Inoue K; Tsubamoto H; Kawata S; Hao H; Ikeda Y; Oku N; Hirota S
J Obstet Gynaecol Res; 2014 Feb; 40(2):576-82. PubMed ID: 24118160
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Leiser AL; Hamid AM; Blanchard R
Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
[TBL] [Abstract][Full Text] [Related]
14. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.
Jakate K; Azimi F; Ali RH; Lee CH; Clarke BA; Rasty G; Shaw PA; Melnyk N; Huntsman DG; Laframboise S; Rouzbahman M
Mod Pathol; 2013 Jan; 26(1):95-105. PubMed ID: 22918161
[TBL] [Abstract][Full Text] [Related]
15. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports.
Garavaglia E; Pella F; Montoli S; Voci C; Taccagni G; Mangili G
Int J Gynecol Cancer; 2010 Oct; 20(7):1197-200. PubMed ID: 21495227
[TBL] [Abstract][Full Text] [Related]
17. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
[TBL] [Abstract][Full Text] [Related]
18. Total Pelvic Exenteration for Recurrent Endometrial Sarcoma - A Case Report.
Suciu N; Bălescu I; Bacalbaşa N
Chirurgia (Bucur); 2015; 110(5):486-9. PubMed ID: 26531797
[TBL] [Abstract][Full Text] [Related]
19. Endolymphatic stromal myosis associated with tamoxifen use.
Eddy GL; Mazur MT
Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
[TBL] [Abstract][Full Text] [Related]
20. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]